Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 3Lymphoma 2Oligodendroglioma 1Neurologic Manifestations 1Neuroblastoma 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Bevacizumab 4Temozolomide 3Irinotecan 3Sorafenib 2pembrolizumab 1ibrutinib 1Vorinostat 1Valproic Acid 1Transcranial Magnetic Stimulation 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Sildenafil Citrate 1Radiosurgery 1Pliability 1Palliative Care 1Lenalidomide 1Laparoscopy 1Exercise 1Equipment and Supplies 1Carboplatin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurologic Manifestations × Bendamustine Hydrochloride × CNS × Clear all
NCT00879073 2012-12-18

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
12 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡